Fycompa
NDC 69616-290, perampanel, suspension, from Catalyst Pharmaceuticals, Inc..
- Product NDC
- 69616-290
- Status
- Listed
- Labeler
- Catalyst Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208277
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/69616-290 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PERAMPANEL.5 mg/mL
Pharmacologic classes
AMPA Receptor Antagonists [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]; UGT1A9 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69616-290-38 | 69616029038 | 340 mL in 1 BOTTLE (69616-290-38) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ec812ea3-de3a-4271-957c-db8f692d1ae3NADAC price for package 69616029038
GET /v1/drugs/nadac/69616029038
Use it
Look up 69616-290 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69616-290 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69616-290. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.